The prevention of mother-to-child transmission of HIV: Are we translating scientific success into programmatic failure?

Current Opinion in HIV and AIDS

Volumn 3, Issue 2, 2008, Pages 139-145

  McIntyre, James ^a   Lallemant, Marc ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Programs for HIV Prevention and Treatment (PHPT)   (Thailand)

Author keywords

Antiretrovirals; Breastfeeding; HIV; Pregnancy; Prevention of mother to child transmission of HIV

Indexed keywords

ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; ANTIRETROVIRUS AGENT; NEVIRAPINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; FAMILY PLANNING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONOTHERAPY; MOTHER CHILD RELATION; NONHUMAN; POSTNATAL CARE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; TREATMENT FAILURE; VIRUS TRANSMISSION;

EID: 40049088150     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e3282f5242a     Document Type: Review

References (57)

1. UNAIDS. AIDS epidemic update: December 2007. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO); 2007. This 2007 update on the state of the global AIDS epidemic includes major downward revisions in country estimates of infection rates, and represents the most accurate assessment to date of the impact of HIV/AIDS.
2. Mofenson LM. Mother-child HIV-1 transmission: Timing and determinants. Obstet Gynecol Clin North Am 1997; 24:759-784.
3. Fowler MG, Lampe MA, Jamieson DJ, et al. Reducing the risk of mother-tochild human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions. Am J Obstet Gynecol 2007; 197 (3 Suppl):S3-S9. This paper is a comprehensive review of the state of PMTCT knowledge in 2007 and discussion of key areas for future development.
4. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331:1173-1180.
5. Centers for Disease Control and Prevention (CDC). Achievements in public health. Reduction in perinatal transmission of HIV infection-United States, 1985-2005. MMWR Morb Mortal Wkly Rep 2006; 55:592-597. This paper is an excellent summary of the progress in reducing MTCT in the United States from the start of the epidemic.
6. Jamieson DJ, Clark J, Kourtis AP, et al. Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States. Am J Obstet Gynecol 2007; 197 (3 Suppl):S26-S32. This paper is a review of current approaches and recommendations for PMTCT in the setting of the United States.
7. European Collaborative Study. The mother-to-child HIV transmission epidemic in Europe: evolving in the East and established in the West. AIDS 2006; 20:1419-1427. This paper is a comparison of the current state of PMTCT in Europe, highlighting the differences between the well resourced and established programmes in Western Europe and the emerging epidemic in low-resource settings in Eastern Europe.
8. European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. The European Mode of Delivery Collaboration. Lancet 1999; 353:1035-1039.
9. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002; 29:484-494.
10. Sansom SL, Harris NS, Sadek R, et al. Toward elimination of perinatal human immunodeficiency virus transmission in the United States: effectiveness of funded prevention programs, 1999-2001. Am J Obstet Gynecol 2007; 197 (3 Suppl):S90-S95. This review of national data demonstrates the substantial reduction in risk of transmission with increasing access to effective antiretroviral treatment.
11. Perinatal HIV Guidelines Working Group. Public Health Service Task Force recommendations for use of antiretroviral drugsin pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States [online resource]. 2 November 2007. http://aidsinfo.nih.gov/ ContentFiles/PerinatalGL.pdf. [Accessed 3 December 2007]. These are comprehensive guidelines for management of HIV pregnant women and for the prevention of mother-to-child transmission in the US setting, regularly updated.
12. British HIV Association, Children's HIV Association. BHIVA and CHIVA guidelines for the management of HIV infection in pregnant women 2008: Consultation draft [online resource]. 2007. http://www.bhiva.org/files/ file1030232.pdf. [Accessed 3 December 2007]. These are the British guidelines for PMTCT interventions.
13. Floridia M, Tamburrini E, Bucceri A, et al. Pregnancy outcomes and antiretroviral treatment in a national cohort of pregnant women with HIV: overall rates and differences according to nationality. BJOG 2007; 114:896-900. Italian data demonstrate the impact of immigration on HIV cases in Europe, with one-third of HIV-positive pregnant women in the 5-year period 2001-2006 being of foreign origin.
14. Cohen MH, Olszewski Y, Webber MP, et al. Women identified with HIV at labor and delivery: testing, disclosing and linking to care challenges. Matern Child Health J 2007; 10 Oct [Epub ahead of print]. This is a discussion of the challenges in management of the vulnerable group of HIV-positive women first identified in labour.
15. Jamieson DJ, Cohen MH, Maupin R, et al. Rapid human immunodeficiency virus-1 testing on labor and delivery in 17 US hospitals: the MIRIAD experience. Am J Obstet Gynecol 2007; 197 (3 Suppl):S72-S82. The authors describe a major study investigating the acceptability and feasibility of HIV testing in labour in the United States.
16. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 1999; 353:773-780.
17. Wiktor SZ, Ekpini E, Karon JM, et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial. Lancet 1999; 353:781-785.
18. The Petra Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double- blind, placebo-controlled trial. Lancet 2002; 359:1178-1186.
19. Leroy V, Sakarovitch C, Cortina-Borja M, et al. Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? AIDS 2005; 19:1865-1875.
20. Lallemant M, Jourdain G, Le Coeur S, et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med 2000; 343:982-991.
21. Guay L, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomized trial. Lancet 1999; 354:795-802.
22. Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004; 351:217-228.
23. Dabis F, Bequet L, Ekouevi DK, et al. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS 2005; 19:309-318.
24. World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants in resource-limited settings: towards universal access. Recommendations for a public health approach. Geneva: World Health Organization; 2006. The WHO guidelines for pregnancy care and PMTCT interventions in low resource settings include the provision of ARV for women in need of treatment and simpler PMTCT regimens for others.
25. United Nations General Assembly. Final declaration of commitment on HIV/AIDS (A/s-26/L.2) [online resource]. New York. 2001. http://www.unaids.org/ UNGASS/index.html. [Accessed 30 May 2003].
26. United Nations General Assembly. Declaration of Commitment on HIV/AIDS: five years later. Follow-up to the outcome of the twenty-sixth special session: implementation of the Declaration of Commitment on HIV/AIDS. Report of the Secretary-General. Sixtieth session, Agenda item 45. New York: United Nations, 2006.
27. Global Partners Forum. Achieving universal access to comprehensive PMTCT services [online resource]. 26 November 2007. http://www.procaare.org/archive/ procaare/200711/msg00013.php. [Accessed 4 December 2007].
28. World Health Organization. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report, April 2007. Geneva: World Health Organization; 2007. This paper is a comprehensive review of global progress in providing antiretroviral treatment and PMTT interventions, including country level estimates of coverage.
29. Boehringer Ingelheim GmbH. 'There is help'. Boehringer Ingelheim Annual Report 2006 [online resource]. 2006. http://www.boehringer-ingelheim.com/ corporate/ar/interviews/help.asp. [Accessed 30 May 2007].
30. UNICEF. Children and AIDS: A stocktaking. New York: UNICEF; 2006.
31. Plipat T, Naiwatanakul T, Rattanasuporn N, et al. Reduction in mother-to-child transmission of HIV in Thailand, 2001-2003: Results from population-based surveillance in six provinces. AIDS 2007; 21:145-151. The authors describe successful Thailand PMTCT programmes.
32. Donnelly J. In Botswana, a success in reducing HIV in newborns. The Boston Globe. 28 August 2007. http://www.iht.com/articles/2007/08/28/africa/ botswana.php. [Accessed 13 December 2007].
33. Creek TL, Ntumy R, Seipone K, et al. Successful introduction of routine opt-out HIV testing in antenatal care in Botswana. J Acquir Immune Defic Syndr 2007; 45:102-107. Description of the acceptability and success of routine opt-out testing for pregnant women in Botswana, and the improvement in uptake of HIV tests.
34. Moses A, Zimba C, Kamanga E, et al. Prevention of mother-to-child transmission: program changes and the effect on uptake of the HIVNET 012 regimen in Malawi. AIDS 2008; 22:83-87. This paper describes the positive impact of changes in HIV testing strategies in an antenatal care setting in Malawi, and the resultant increase to 99% uptake of HIV testing.
35. Holmes WR, Savage F. Exclusive breastfeeding and HIV. Lancet 2007; 369:1065-1066.
36. UNAIDS. 2006 Report on the Global AIDS Epidemic. Geneva: UNAIDS; 2006.
37. Kourtis AP, Jamieson DJ, de Vincenzi I, et al. Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments. Am J Obstet Gynecol 2007; 197 (3 Suppl):S113-S122. This paper is a review of current evidence on interventions to prevent transmission through breastfeeding and potential new options for the future.
38. World Health Organization. New data on the prevention of mother-to-child transmission of HIV and their policy implications: conclusions and recommendations. WHO Technical Consultation on behalf of the UNFPA/UNICEF/WHO/UNAIDS Inter-Agency Task Team on Mother-to-Child Transmission of HIV. 11-13 October 2000. WHO/RHR/01.28ed., 2001. Geneva: World Health Organization; 2001.
39. Coetzee D, Hilderbrand K, Boulle A, et al. Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa. Bull World Health Organ 2005; 83:489-494.
40. Leroy V, Sakarovitch C, Viho I, et al. Acceptability of formula-feeding to prevent HIV postnatal transmission, Abidjan, Cote d'Ivoire: ANRS 1201/1202 Ditrame Plus Study. J Acquir Immune Defic Syndr 2007; 44:77-86. This paper shows the high acceptability of replacement feeding in Abidjan, and good adherence to infant feeding choice.
41. Coutsoudis A, Pillay K, Spooner E, et al. Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study. South African Vitamin A Study Group. Lancet 1999; 354:471-476.
42. Thior I, Lockman S, Smeaton LM, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs. formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA 2006; 296:794-805. This paper shows no difference in HIV-free survival in infants breastfed with zidovudine prophylaxis compared with replacement-fed infants in Botswana.
43. Sinkala M, Kuhn L, Kankasa C, et al. No benefit of early cessation of breastfeeding at 4 months on HIV-free survival of infants born to HIV-infected mothers in Zambia: The Zambia Exclusive Breastfeeding Study [abstract]. In: 14th Conference on Retroviruses and Opportunistic Infections; 25-28 February 2007; Los Angeles. Alexandria: 25-28 February 2007. Abstract 74.
44. Chopra M, Rollins N. Infant feeding in the time of HIV: Assessment of infant feeding policy and programmes in four African countries scaling up prevention of mother to child transmission programmes. Arch Dis Child 2007; 8 Aug [Epub ahead of print]. The authors describe infant feeding policy issues in high prevalence African settings.
45. Bland RM, Rollins NC, Coovadia HM, et al. Infant feeding counselling for HIV-infected and uninfected women: appropriateness of choice and practice. Bull World Health Organ 2007; 85:289-296. Assessment of infant feeding counselling demonstrates that adherence to appropriate feeding choice was good and that spillover of suboptimal feeding practices to HIV-negative women is minimal, with appropriate counselling and support.
46. Doherty T, Chopra M, Jackson D, et al. Effectiveness of the WHO/UNICEF guidelines on infant feeding for HIV-positive women: results from a prospective cohort study in South Africa. AIDS 2007; 21:1791-1797. This provides evaluation of criteria associated with the success or failure of replacement feeding by HIV-positive mothers in three South Africa sites.
47. Shapiro RL, Ndung'u T, Lockman S, et al. Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk. J Infect Dis 2005; 192:713-719.
48. World Health Organization. Strategic approaches to the prevention of HIV infection in infants. Report of a WHO meeting, Morges, Switzerland, 20-22 March 2002. Geneva: World Health Organization; 2002.
49. World Health Organization. Treat, train, retain: the AIDS health workforce plan: report on the Consultation on AIDS Human Resources for Health, WHO, Geneva, 11-12 May 2006. Geneva: World Health Organization; 2006.
50. Kanshana S, Simonds RJ. National program for preventing mother-child HIV transmission in Thailand: successful implementation and lessons learned. AIDS 2002; 16:953-959.
51. Chasombat S, Lertpiriyasuwat C, Thanprasertsuk S, et al. The National Access to Antiretroviral Program for PHA (NAPHA) in Thailand. Southeast Asian J Trop Med Public Health 2006; 37:704-715. This paper is an historical review of Thailand's ARV programme, demonstrating that local leadership, comprehensive training, adherence, and coordination are essential to program effectiveness and sustainability.
52. Le Coeur S, Jourdain G, Collins I, et al. Prevention of mother-to-child transmission of HIV in Thailand: striding towards access to HAART for the family. In: Lu Y, Essex M, editors. AIDS in Asia. New York, New York: Kluwer Academic/Plenum Publishers; 2004. pp. 457-469.
53. National Department of Health South Africa. National HIV and Syphilis Prevalence Survey, South Africa, 2006. Summary. Pretoria: National Department of Health of South Africa; 2007.
54. Nattrass N. Mortal Combat: AIDS denialism and the struggle for antiretrovirals in South Africa. Durban: University of KwaZulu Natal Press; 2007.
55. Baleta A. South African court again tells government to increase access to AIDS drug. Lancet 2002; 359:1132.
56. Meyers T, Moultrie H, Sherman G, et al. Management of HIV infected children. In: Ijumba P, Padarath A, editors. South African Health Review 2006. Durban: Health Systems Trust; 2006. This paper is an overview of paediatric HIV care in the South African setting, including some assessment of PMTCT services in the country.
57. Inter-Agency Task Team on Prevention of HIV Infection in Pregnant Women, Mothers and their Children. Guidance on global scale -up of the prevention of mother-to-child transmission of HIV. Towards universal access for women, infants and young children and eliminating HIV and AIDS among children. Geneva: World Health Organization; 2007. This review of successes and challenges in PMTCT scale up globally provides lessons learned and guidance on implementation issues.